294 related articles for article (PubMed ID: 34814392)
1. [Study on the relationship between non-alcoholic fatty liver disease and sarcopenia in type 2 diabetes mellitus].
Jiang H; Cheng QF; Zhu BZ; Yang Q
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):977-982. PubMed ID: 34814392
[No Abstract] [Full Text] [Related]
2. The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes.
Hashimoto Y; Osaka T; Fukuda T; Tanaka M; Yamazaki M; Fukui M
Endocr J; 2016 Oct; 63(10):877-884. PubMed ID: 27397679
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.
Alferink LJM; Trajanoska K; Erler NS; Schoufour JD; de Knegt RJ; Ikram MA; Janssen HLA; Franco OH; Metselaar HJ; Rivadeneira F; Darwish Murad S
J Bone Miner Res; 2019 Jul; 34(7):1254-1263. PubMed ID: 31074909
[TBL] [Abstract][Full Text] [Related]
4. Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.
Kim HY; Kim CW; Park CH; Choi JY; Han K; Merchant AT; Park YM
Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):39-47. PubMed ID: 26818542
[TBL] [Abstract][Full Text] [Related]
5. Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes.
Seo DH; Lee YH; Park SW; Choi YJ; Huh BW; Lee E; Huh KB; Kim SH; Cha BS
Diabetes Metab; 2020 Oct; 46(5):362-369. PubMed ID: 31689496
[TBL] [Abstract][Full Text] [Related]
6. Associations between muscle mass, strength, and performance and non-alcoholic fatty liver disease.
Rigor J; Vasconcelos R; Lopes R; Moreira T; Barata P; Martins-Mendes D
Minerva Gastroenterol (Torino); 2023 Sep; 69(3):374-381. PubMed ID: 35343663
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.
Kouvari M; Polyzos SA; Chrysohoou C; Skoumas J; Pitsavos CS; Panagiotakos DB; Mantzoros CS
Clin Nutr; 2022 Jun; 41(6):1281-1289. PubMed ID: 35504171
[TBL] [Abstract][Full Text] [Related]
8. Non-Alcoholic Fatty Liver Disease with Sarcopenia and Carotid Plaque Progression Risk in Patients with Type 2 Diabetes Mellitus.
Cho Y; Park HS; Huh BW; Lee YH; Seo SH; Seo DH; Ahn SH; Hong S; Kim SH
Diabetes Metab J; 2023 Mar; 47(2):232-241. PubMed ID: 36653888
[TBL] [Abstract][Full Text] [Related]
9. The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus.
Zhang X; He Z; Si Q; Hu X; Yang L; Gu X; Du L; Wang L; Pan L; Li Y; Li J; Yang B; Gu X
J Diabetes Res; 2022; 2022():2229139. PubMed ID: 36387941
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
Lee YH; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH
Hepatology; 2016 Mar; 63(3):776-86. PubMed ID: 26638128
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease and sarcopenia in a Western population (NHANES III): The importance of sarcopenia definition.
Peng TC; Wu LW; Chen WL; Liaw FY; Chang YW; Kao TW
Clin Nutr; 2019 Feb; 38(1):422-428. PubMed ID: 29287676
[TBL] [Abstract][Full Text] [Related]
12. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study.
Hong HC; Hwang SY; Choi HY; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
Hepatology; 2014 May; 59(5):1772-8. PubMed ID: 23996808
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
[TBL] [Abstract][Full Text] [Related]
14. Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008-2011).
Hong KS; Kim MC; Ahn JH
Int J Chron Obstruct Pulmon Dis; 2020; 15():1005-1014. PubMed ID: 32440112
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors.
Prasetya IB; Hasan I; Wisnu W; Rumende CM
Acta Med Indones; 2017 Apr; 49(2):91-98. PubMed ID: 28790222
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia is associated with the presence of nonalcoholic fatty liver disease in Zhejiang Province, China: a cross-sectional observational study.
Wang YM; Zhu KF; Zhou WJ; Zhang Q; Deng DF; Yang YC; Lu WW; Xu J; Yang YM
BMC Geriatr; 2021 Jan; 21(1):55. PubMed ID: 33446095
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank.
Freer CL; George ES; Tan SY; Abbott G; Scott D; Daly RM
Calcif Tissue Int; 2024 Jun; 114(6):592-602. PubMed ID: 38678512
[TBL] [Abstract][Full Text] [Related]
18. A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity.
Kashiwagi K; Takayama M; Fukuhara K; Shimizu-Hirota R; Chu PS; Nakamoto N; Inoue N; Iwao Y; Kanai T
Clin Nutr ESPEN; 2020 Aug; 38():86-93. PubMed ID: 32690183
[TBL] [Abstract][Full Text] [Related]
19. The Relationship between NAFLD and Sarcopenia in Elderly Patients.
Zhai Y; Xiao Q; Miao J
Can J Gastroenterol Hepatol; 2018; 2018():5016091. PubMed ID: 29785395
[TBL] [Abstract][Full Text] [Related]
20. Free Triiodothyronine Is Independently Associated with Nonalcoholic Fatty Liver Disease in Hospitalized Type 2 Diabetes Mellitus Patients.
Shi R; Lin C; Hong Y; Xia X; Chen Y; Li S; Xiu L
Biomed Res Int; 2021; 2021():8868339. PubMed ID: 33532498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
